首页 > 最新文献

JOURNAL OF MEDICAL INVESTIGATION最新文献

英文 中文
Laparoscopic pancreaticoduodenectomy in patients with a history of right hemicolectomy : A report of three cases. 有右半结肠切除术史的腹腔镜胰十二指肠切除术:附3例报告。
IF 0.7 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2152/jmi.70.285
Hayato Ohya, Atsuyuki Maeda, Yuichi Takayama, Takamasa Takahashi, Hiroki Aoyama, Takahiro Hosoi, Kazuaki Seita, Yuji Kaneoka

Laparoscopic pancreaticoduodenectomy (LPD) has been widely adopted in institutions with sufficiently skilled practitioners. This technique requires attentive dissection around the superior mesenteric vein (SMV) and artery. Dissection around the SMV and Henle's trunk is one of the key aspects of right hemicolectomy (RHC) ; adhesions and fibrosis around these vessels may impede LPD in patients with a history of RHC. We encountered three cases of periampullary tumors in patients with a history of RHC who were successfully treated with LPD. Cases 1, 2, and 3 were of 60-, 73-, and 74-year-old men with periampullary tumors. The operative durations in cases 1, 2, and 3 were 316, 267, and 265 min, respectively. The estimated blood loss volumes in cases 1, 2, and 3 were 20, 50, and 720 mL, respectively. The postoperative hospital stay durations in cases 1, 2, and 3 were of 13, 35, and 15 days, respectively. In conclusion, LPD following RHC may be safely completed with laparoscopy. J. Med. Invest. 70 : 285-289, February, 2023.

腹腔镜胰十二指肠切除术(LPD)已被广泛采用的机构有足够熟练的从业人员。这项技术需要仔细地剥离肠系膜上静脉(SMV)和动脉。右半结肠切除术(RHC)的一个关键方面是SMV和Henle's干周围的解剖;这些血管周围的粘连和纤维化可能阻碍有RHC病史患者的LPD。我们遇到了三例壶腹周围肿瘤患者有RHC病史,他们成功地用LPD治疗。病例1、2和3分别为60岁、73岁和74岁男性壶腹周围肿瘤患者。病例1、2、3的手术时间分别为316、267、265 min。病例1、2和3的估计失血量分别为20、50和720 mL。病例1、2、3术后住院时间分别为13、35、15天。总之,RHC后的LPD可以在腹腔镜下安全完成。中华医学杂志,2016,31(2):379 - 379。
{"title":"Laparoscopic pancreaticoduodenectomy in patients with a history of right hemicolectomy : A report of three cases.","authors":"Hayato Ohya,&nbsp;Atsuyuki Maeda,&nbsp;Yuichi Takayama,&nbsp;Takamasa Takahashi,&nbsp;Hiroki Aoyama,&nbsp;Takahiro Hosoi,&nbsp;Kazuaki Seita,&nbsp;Yuji Kaneoka","doi":"10.2152/jmi.70.285","DOIUrl":"https://doi.org/10.2152/jmi.70.285","url":null,"abstract":"<p><p>Laparoscopic pancreaticoduodenectomy (LPD) has been widely adopted in institutions with sufficiently skilled practitioners. This technique requires attentive dissection around the superior mesenteric vein (SMV) and artery. Dissection around the SMV and Henle's trunk is one of the key aspects of right hemicolectomy (RHC) ; adhesions and fibrosis around these vessels may impede LPD in patients with a history of RHC. We encountered three cases of periampullary tumors in patients with a history of RHC who were successfully treated with LPD. Cases 1, 2, and 3 were of 60-, 73-, and 74-year-old men with periampullary tumors. The operative durations in cases 1, 2, and 3 were 316, 267, and 265 min, respectively. The estimated blood loss volumes in cases 1, 2, and 3 were 20, 50, and 720 mL, respectively. The postoperative hospital stay durations in cases 1, 2, and 3 were of 13, 35, and 15 days, respectively. In conclusion, LPD following RHC may be safely completed with laparoscopy. J. Med. Invest. 70 : 285-289, February, 2023.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"70 1.2","pages":"285-289"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9446532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resilience in cancer care : What should nurses do? 癌症护理中的复原力:护士应该怎么做?
IF 0.7 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2152/jmi.70.1
Sun Leqi, Kazuya Kondo, Takae Bando, Yoshie Imai

Cancer is a serious threat to human health worldwide. Attention to the quality of life (QoL) of cancer patients is increasingly recognized as an important component of and a fundamental task in cancer care. Recent studies illustrate that resilience is a key biological factor affecting cancer patients' health status and QoL. However, few studies have focused on resilience during medical procedures of cancer patients from the perspective of nursing. In this study, we summarize recent literature exploring the clinical significance of resilience in oncology nursing, propose strategies for cancer care to improve the QoL of patients through interventions on resilience, and focus on emerging theories in oncology nursing. In summary, this will emphasize the importance of resilience in oncology nursing and benefit the clinical practices that improve patients' QoL and reduce the social burden caused by cancer. J. Med. Invest. 70 : 1-6, February, 2023.

癌症是世界范围内对人类健康的严重威胁。关注癌症患者的生活质量(QoL)越来越被认为是癌症治疗的重要组成部分和基本任务。近年来的研究表明,弹性是影响癌症患者健康状况和生活质量的关键生物学因素。然而,很少有研究从护理的角度关注癌症患者在医疗过程中的恢复力。在本研究中,我们总结了近年来探讨韧性在肿瘤护理中的临床意义的文献,提出了通过干预韧性来提高患者生活质量的癌症护理策略,并重点介绍了肿瘤护理中的新兴理论。综上所述,这将强调韧性在肿瘤护理中的重要性,有利于临床实践,提高患者的生活质量,减轻癌症带来的社会负担。中华医学杂志,2016,31(2):1-6。
{"title":"Resilience in cancer care : What should nurses do?","authors":"Sun Leqi,&nbsp;Kazuya Kondo,&nbsp;Takae Bando,&nbsp;Yoshie Imai","doi":"10.2152/jmi.70.1","DOIUrl":"https://doi.org/10.2152/jmi.70.1","url":null,"abstract":"<p><p>Cancer is a serious threat to human health worldwide. Attention to the quality of life (QoL) of cancer patients is increasingly recognized as an important component of and a fundamental task in cancer care. Recent studies illustrate that resilience is a key biological factor affecting cancer patients' health status and QoL. However, few studies have focused on resilience during medical procedures of cancer patients from the perspective of nursing. In this study, we summarize recent literature exploring the clinical significance of resilience in oncology nursing, propose strategies for cancer care to improve the QoL of patients through interventions on resilience, and focus on emerging theories in oncology nursing. In summary, this will emphasize the importance of resilience in oncology nursing and benefit the clinical practices that improve patients' QoL and reduce the social burden caused by cancer. J. Med. Invest. 70 : 1-6, February, 2023.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"70 1.2","pages":"1-6"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9451923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibitory Effects of Aspirin and Cilostazol on Intracellular Ca2+ Mobilization and Aggregation in Thrombin-activated Human Platelets. 阿司匹林和西洛他唑对凝血酶活化的人血小板细胞内Ca2+动员和聚集的抑制作用。
IF 0.7 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2152/jmi.70.94
Atsumi Sone, Kensaku Aki, Toshiyuki Yasui, Eiji Hosoi

Platelets play an important role in physiological hemostatic mechanisms. In contrast, platelet activation has been implicated in pathological conditions, such as atherosclerosis, angiogenesis, and inflammation. Thrombin is considered to be of particular pathological importance as a platelet-activating substance, and thrombin-activated platelets are detected in the blood of patients with advanced occlusive arterial disease. Ca2+ acts as a second messenger in platelet activation, and the regulation of intracellular Ca2+ concentrations ([Ca2+]i) is important for controlling platelet functions. However, changes in [Ca2+]i by antiplatelet agents remain unclear. Therefore, we herein investigated the relationship between [Ca2+]i and the intensity of platelet aggregation after a thrombin stimulation, the relationship between [Ca2+]i and the intensity of platelet aggregation by antiplatelet agents, and the effects of antiplatelet agents on thrombin-activated platelets as a surrogate platelet model for arterial occlusive disease. Fura2-loaded platelets were treated with phosphate-buffered saline or a low concentration of thrombin (0.005 U/mL), followed by antiplatelet agents (aspirin or cilostazol), and changes in [Ca2+]i and the intensity of platelet aggregation by the thrombin stimulation were measured using fluorescence spectrophotometry. Changes in [Ca2+]i and the intensity of platelet aggregation after the thrombin stimulation as well as the relationship between [Ca2+]i and the intensity of platelet aggregation by antiplatelet agents indicated that cilostazol exerted stronger antiplatelet effects than aspirin and also that antiplatelet effects may be attenuated in thrombin-activated platelets. The present results also suggest the utility of thrombin-activated platelets as a surrogate platelet model for arterial occlusive disease. These results may contribute to future drug development for antiplatelet therapy. J. Med. Invest. 70 : 94-100, February, 2023.

血小板在生理止血机制中起重要作用。相反,血小板活化与病理条件有关,如动脉粥样硬化、血管生成和炎症。凝血酶作为一种血小板活化物质被认为具有特殊的病理意义,在晚期动脉闭塞性疾病患者的血液中检测到凝血酶活化的血小板。Ca2+作为血小板激活的第二信使,调节细胞内Ca2+浓度([Ca2+]i)对控制血小板功能很重要。然而,抗血小板药物对[Ca2+]i的影响尚不清楚。因此,我们在此研究了凝血酶刺激后[Ca2+]i与血小板聚集强度之间的关系,抗血小板药物与血小板聚集强度之间的关系,以及抗血小板药物对凝血酶活化血小板的影响,作为动脉闭塞性疾病的替代血小板模型。用磷酸盐缓冲盐水或低浓度凝血酶(0.005 U/mL)处理载富拉素的血小板,然后使用抗血小板药物(阿司匹林或西洛他唑),用荧光分光光度法测量凝血酶刺激下[Ca2+]i的变化和血小板聚集强度。凝血酶刺激后[Ca2+]i与血小板聚集强度的变化以及抗血小板药物对[Ca2+]i与血小板聚集强度的关系提示西洛他唑的抗血小板作用强于阿司匹林,且在凝血酶活化的血小板中抗血小板作用可能减弱。目前的结果还表明,凝血酶活化血小板作为动脉闭塞性疾病的替代血小板模型的效用。这些结果可能有助于未来抗血小板治疗药物的开发。中华医学杂志,30(2),2023。
{"title":"Inhibitory Effects of Aspirin and Cilostazol on Intracellular Ca<sup>2+</sup> Mobilization and Aggregation in Thrombin-activated Human Platelets.","authors":"Atsumi Sone,&nbsp;Kensaku Aki,&nbsp;Toshiyuki Yasui,&nbsp;Eiji Hosoi","doi":"10.2152/jmi.70.94","DOIUrl":"https://doi.org/10.2152/jmi.70.94","url":null,"abstract":"<p><p>Platelets play an important role in physiological hemostatic mechanisms. In contrast, platelet activation has been implicated in pathological conditions, such as atherosclerosis, angiogenesis, and inflammation. Thrombin is considered to be of particular pathological importance as a platelet-activating substance, and thrombin-activated platelets are detected in the blood of patients with advanced occlusive arterial disease. Ca<sup>2+</sup> acts as a second messenger in platelet activation, and the regulation of intracellular Ca<sup>2+</sup> concentrations ([Ca<sup>2+</sup>]i) is important for controlling platelet functions. However, changes in [Ca<sup>2+</sup>]i by antiplatelet agents remain unclear. Therefore, we herein investigated the relationship between [Ca<sup>2+</sup>]i and the intensity of platelet aggregation after a thrombin stimulation, the relationship between [Ca<sup>2+</sup>]i and the intensity of platelet aggregation by antiplatelet agents, and the effects of antiplatelet agents on thrombin-activated platelets as a surrogate platelet model for arterial occlusive disease. Fura2-loaded platelets were treated with phosphate-buffered saline or a low concentration of thrombin (0.005 U/mL), followed by antiplatelet agents (aspirin or cilostazol), and changes in [Ca<sup>2+</sup>]i and the intensity of platelet aggregation by the thrombin stimulation were measured using fluorescence spectrophotometry. Changes in [Ca<sup>2+</sup>]i and the intensity of platelet aggregation after the thrombin stimulation as well as the relationship between [Ca<sup>2+</sup>]i and the intensity of platelet aggregation by antiplatelet agents indicated that cilostazol exerted stronger antiplatelet effects than aspirin and also that antiplatelet effects may be attenuated in thrombin-activated platelets. The present results also suggest the utility of thrombin-activated platelets as a surrogate platelet model for arterial occlusive disease. These results may contribute to future drug development for antiplatelet therapy. J. Med. Invest. 70 : 94-100, February, 2023.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"70 1.2","pages":"94-100"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9501386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Impact of L-type amino acid transporter 1 on intrahepatic cholangiocarcinoma. l型氨基酸转运蛋白1对肝内胆管癌的影响。
IF 0.7 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2152/jmi.70.160
Baasansuren Selenge, Shinichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Chie Takasu, Hiroki Teraoku, Shohei Okikawa, Mitsuo Shimada

Background: Amino acid transporters, such as L-type amino acid transporter 1 (LAT1), have an effect on tumor growth, metastasis, and survival of various solid tumors. However, the role of LAT1 in patients with intrahepatic cholangiocarcinoma (IHCC) remains unknown.

Methods: Forty-six patients who had undergone initial hepatic resection for IHCC at Tokushima University Hospital were enrolled in this study. Immunohistochemical analysis of LAT1 and phosphorylated Akt (p-AKT) was performed using resected specimens. Clinicopathological factors, including prognosis, were analyzed between LAT1-high and LAT1-low groups.

Results: The LAT1-high group showed a higher proportion of periductal infiltrating type and higher carcinoembryonic antigen/carbohydrate antigen 19-9 levels compared with the LAT1-low group. Multivariate analysis revealed that LAT1-high expression was an independent prognostic factor for disease-free survival. Furthermore, the proportion of p-AKT positivity was higher in the LAT1-high group than in the LAT1-low group.

Conclusions: LAT1 expression was associated with poor prognosis of IHCC and higher p-Akt expression. J. Med. Invest. 70 : 160-165, February, 2023.

背景:氨基酸转运蛋白,如l型氨基酸转运蛋白1 (LAT1),对多种实体肿瘤的生长、转移和存活都有影响。然而,LAT1在肝内胆管癌(IHCC)患者中的作用尚不清楚。方法:选取46例在德岛大学医院接受肝切除术的IHCC患者作为研究对象。使用切除的标本进行LAT1和磷酸化Akt (p-AKT)的免疫组化分析。分析lat1高、低两组患者的临床病理因素及预后。结果:与低lat1组相比,高lat1组导管周浸润型比例更高,癌胚抗原/碳水化合物抗原19-9水平更高。多因素分析显示,lat1高表达是无病生存的独立预后因素。此外,高lat1组的p-AKT阳性比例高于低lat1组。结论:LAT1表达与IHCC预后不良及p-Akt表达升高有关。中华医学杂志,2016,30(2):369 - 369。
{"title":"Impact of L-type amino acid transporter 1 on intrahepatic cholangiocarcinoma.","authors":"Baasansuren Selenge,&nbsp;Shinichiro Yamada,&nbsp;Yuji Morine,&nbsp;Tetsuya Ikemoto,&nbsp;Yu Saito,&nbsp;Chie Takasu,&nbsp;Hiroki Teraoku,&nbsp;Shohei Okikawa,&nbsp;Mitsuo Shimada","doi":"10.2152/jmi.70.160","DOIUrl":"https://doi.org/10.2152/jmi.70.160","url":null,"abstract":"<p><strong>Background: </strong>Amino acid transporters, such as L-type amino acid transporter 1 (LAT1), have an effect on tumor growth, metastasis, and survival of various solid tumors. However, the role of LAT1 in patients with intrahepatic cholangiocarcinoma (IHCC) remains unknown.</p><p><strong>Methods: </strong>Forty-six patients who had undergone initial hepatic resection for IHCC at Tokushima University Hospital were enrolled in this study. Immunohistochemical analysis of LAT1 and phosphorylated Akt (p-AKT) was performed using resected specimens. Clinicopathological factors, including prognosis, were analyzed between LAT1-high and LAT1-low groups.</p><p><strong>Results: </strong>The LAT1-high group showed a higher proportion of periductal infiltrating type and higher carcinoembryonic antigen/carbohydrate antigen 19-9 levels compared with the LAT1-low group. Multivariate analysis revealed that LAT1-high expression was an independent prognostic factor for disease-free survival. Furthermore, the proportion of p-AKT positivity was higher in the LAT1-high group than in the LAT1-low group.</p><p><strong>Conclusions: </strong>LAT1 expression was associated with poor prognosis of IHCC and higher p-Akt expression. J. Med. Invest. 70 : 160-165, February, 2023.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"70 1.2","pages":"160-165"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9837876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of daikenchuto (TU-100) on carcinogenesis in non-alcoholic steatohepatitis. 大kenchuto (TU-100)对非酒精性脂肪性肝炎癌变的影响。
IF 0.7 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2152/jmi.70.66
Shinichiro Yamada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saito, Mayuko Shimizu, Koichi Tsuneyama, Mitsue Nishiyama, Shiori Ishizawa, Mitsuo Shimada

Background: Non-alcoholic steatohepatitis (NASH) is associated with a higher risk of hepatocellular carcinoma (HCC), and the importance of the gut?liver axis has been recognized in NASH-associated HCC. We investigated the effect of TU-100 on the intestinal microbiome and hepatocarcinogenesis in a NASH model.

Methods: Seven-week-old Tsumura Suzuki obese diabetes mice, a model that shows the spontaneous onset of NASH and HCC, were used. They were divided into a TU-100 treated group and a control group. Mice were sacrificed at 24 and 48 weeks to evaluate hepatic steatosis, fibrosis, carcinogenesis, cytokine expression, and microbiome abundance.

Results: At 24 weeks, the TU-100 group showed significantly lower expression of IL6, IL1B, and ACTA2 mRNA in the liver (P?

Conclusions: TU-100 regulates the intestinal microbiome and may suppress subsequent hepatocarcinogenesis in the NASH model. J. Med. Invest. 70 : 66-73, February, 2023.

背景:非酒精性脂肪性肝炎(NASH)与肝细胞癌(HCC)的高风险相关,肠道的重要性?肝轴已在nash相关HCC中得到确认。我们在NASH模型中研究了TU-100对肠道微生物组和肝癌发生的影响。方法:使用7周龄Tsumura Suzuki肥胖糖尿病小鼠,这是一种显示NASH和HCC自发发病的模型。将其分为TU-100治疗组和对照组。小鼠在24周和48周时被处死,以评估肝脂肪变性、纤维化、癌变、细胞因子表达和微生物群丰度。结果:24周时,TU-100组小鼠肝脏中IL6、IL1B、ACTA2 mRNA表达明显降低(P?结论:在NASH模型中,TU-100调节肠道微生物组,并可能抑制随后的肝癌发生。中华医学杂志,2016,33(2):391 - 391。
{"title":"Effect of daikenchuto (TU-100) on carcinogenesis in non-alcoholic steatohepatitis.","authors":"Shinichiro Yamada,&nbsp;Yuji Morine,&nbsp;Satoru Imura,&nbsp;Tetsuya Ikemoto,&nbsp;Yu Saito,&nbsp;Mayuko Shimizu,&nbsp;Koichi Tsuneyama,&nbsp;Mitsue Nishiyama,&nbsp;Shiori Ishizawa,&nbsp;Mitsuo Shimada","doi":"10.2152/jmi.70.66","DOIUrl":"https://doi.org/10.2152/jmi.70.66","url":null,"abstract":"<p><strong>Background: </strong>Non-alcoholic steatohepatitis (NASH) is associated with a higher risk of hepatocellular carcinoma (HCC), and the importance of the gut?liver axis has been recognized in NASH-associated HCC. We investigated the effect of TU-100 on the intestinal microbiome and hepatocarcinogenesis in a NASH model.</p><p><strong>Methods: </strong>Seven-week-old Tsumura Suzuki obese diabetes mice, a model that shows the spontaneous onset of NASH and HCC, were used. They were divided into a TU-100 treated group and a control group. Mice were sacrificed at 24 and 48 weeks to evaluate hepatic steatosis, fibrosis, carcinogenesis, cytokine expression, and microbiome abundance.</p><p><strong>Results: </strong>At 24 weeks, the TU-100 group showed significantly lower expression of IL6, IL1B, and ACTA2 mRNA in the liver (P?<?0.05). At 48 weeks, the TU-100 group showed significantly lower levels of serum alanine aminotransferase. The TU-100 group also showed a lower rate of NASH than the control group (28% vs 72%?;?P?=?0.1). Tumor diameter was significantly smaller in the TU-100 group compared with that in the control group (P?<?0.05). Regarding the intestinal microbiome, the genera Blautia and Ruminococcus were increased in the TU-100 group (P?<?0.05), whereas Dorea and Erysipelotrichaceae were decreased in the TU-100 group (P?<?0.05).</p><p><strong>Conclusions: </strong>TU-100 regulates the intestinal microbiome and may suppress subsequent hepatocarcinogenesis in the NASH model. J. Med. Invest. 70 : 66-73, February, 2023.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"70 1.2","pages":"66-73"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9798931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of nutritional status and changes of body composition on the prognosis of metastatic renal cell carcinoma patients. 营养状况及身体成分变化对转移性肾癌患者预后的影响。
IF 0.7 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2152/jmi.70.80
Keisuke Ozaki, Tomoya Fukawa, Kei Daizumoto, Yutaro Sasaki, Yoshiteru Ueno, Megumi Tsuda, Takayuki Uchida, Yoshito Kusuhara, Yasuyo Yamamoto, Kunihisa Yamaguchi, Masayuki Takahashi, Hiro-Omi Kanayam

Purpose: This study aimed to analyze the impact of patients' nutritional status and changes in body composition on the prognosis of metastatic renal cell carcinoma (mRCC) patients who received systemic therapy with tyrosine kinase inhibitors (TKIs).

Methods: A total of 57 mRCC patients who received systemic therapy with TKIs as first-line therapy at our facility between November 2004 and October 2018 were included. The Prognostic Nutritional Index (PNI) was used to evaluate their nutritional status. The volumes of skeletal muscle mass and fat tissue were calculated using the SYNAPSE VINCENT system. The effects of nutritional status and body composition of mRCC patients on progression-free survival (PFS) and overall survival (OS) were analyzed using Cox regression methods.

Results: Low PNI at the start of systemic therapy was a significant prognostic predictor for OS (HR 3.807 [95% CI 1.205-12.027], P=0.046), and it was related to loss of muscle mass three months after systemic therapy. Although the loss of muscle mass at the start of systemic therapy was not associated with OS, loss of muscle mass during treatment predicted worse OS.

Conclusions: Nutritional status of mRCC patients may predict changes in body composition and be associated with their prognosis. J. Med. Invest. 70 : 80-87, February, 2023.

目的:本研究旨在分析患者营养状况和体成分变化对接受酪氨酸激酶抑制剂(TKIs)全身治疗的转移性肾细胞癌(mRCC)患者预后的影响。方法:在2004年11月至2018年10月期间,共有57名mRCC患者在我们的设施接受了TKIs作为一线治疗的全身治疗。采用预后营养指数(PNI)评价患者的营养状况。使用SYNAPSE VINCENT系统计算骨骼肌质量和脂肪组织的体积。采用Cox回归方法分析mRCC患者营养状况和体成分对无进展生存期(PFS)和总生存期(OS)的影响。结果:全身治疗开始时的低PNI是OS的重要预后预测因子(HR 3.807 [95% CI 1.205-12.027], P=0.046),并且与全身治疗后3个月肌肉量的减少有关。虽然全身治疗开始时肌肉量的减少与OS无关,但治疗期间肌肉量的减少预示着更糟糕的OS。结论:mRCC患者的营养状况可以预测其身体成分的变化,并与预后相关。中华医学杂志,2016,27(2):379 - 379。
{"title":"The impact of nutritional status and changes of body composition on the prognosis of metastatic renal cell carcinoma patients.","authors":"Keisuke Ozaki,&nbsp;Tomoya Fukawa,&nbsp;Kei Daizumoto,&nbsp;Yutaro Sasaki,&nbsp;Yoshiteru Ueno,&nbsp;Megumi Tsuda,&nbsp;Takayuki Uchida,&nbsp;Yoshito Kusuhara,&nbsp;Yasuyo Yamamoto,&nbsp;Kunihisa Yamaguchi,&nbsp;Masayuki Takahashi,&nbsp;Hiro-Omi Kanayam","doi":"10.2152/jmi.70.80","DOIUrl":"https://doi.org/10.2152/jmi.70.80","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to analyze the impact of patients' nutritional status and changes in body composition on the prognosis of metastatic renal cell carcinoma (mRCC) patients who received systemic therapy with tyrosine kinase inhibitors (TKIs).</p><p><strong>Methods: </strong>A total of 57 mRCC patients who received systemic therapy with TKIs as first-line therapy at our facility between November 2004 and October 2018 were included. The Prognostic Nutritional Index (PNI) was used to evaluate their nutritional status. The volumes of skeletal muscle mass and fat tissue were calculated using the SYNAPSE VINCENT system. The effects of nutritional status and body composition of mRCC patients on progression-free survival (PFS) and overall survival (OS) were analyzed using Cox regression methods.</p><p><strong>Results: </strong>Low PNI at the start of systemic therapy was a significant prognostic predictor for OS (HR 3.807 [95% CI 1.205-12.027], P=0.046), and it was related to loss of muscle mass three months after systemic therapy. Although the loss of muscle mass at the start of systemic therapy was not associated with OS, loss of muscle mass during treatment predicted worse OS.</p><p><strong>Conclusions: </strong>Nutritional status of mRCC patients may predict changes in body composition and be associated with their prognosis. J. Med. Invest. 70 : 80-87, February, 2023.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"70 1.2","pages":"80-87"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9799368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A case of atopic cough with aphonia showed a prominent response to a histamine H1 receptor antagonist. 一例特应性咳嗽伴发音障碍患者对组胺 H1 受体拮抗剂有明显反应。
IF 0.7 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2152/jmi.70.281
Masaki Hanibuchi, Atsushi Mitsuhashi, Atsuro Saijo, Tatsuya Kajimoto, Seidai Sato, Tetsuya Kitagawa, Yasuhiko Nishioka

A 33-year-old woman admitted to our hospital for further examination of severe non-productive cough lasting for about two months. Her symptom did not ameliorate by treatments including long acting β2 agonists. She had a medical history of drug allergy to non-steroidal anti-inflammatory drugs. At the initial visit, she could not speak at all and communicated with us in writing. Chest auscultation revealed no wheezes, rhonchi and other crackles. Laboratory findings showed a mild eosinophilia with normal total and specific serum immunoglobulin E. The results of an electrocardiogram, a chest X-ray and a chest CT were unremarkable. A fractional exhaled nitric oxide value was within normal limit. Based on these observations, a diagnosis of atopic cough (AC) was suspected, and we started treatment with a histamine H1 receptor antagonist (H1-RA). She had become able to speak again in association with complete disappearance of cough by eight-weeks after treatment initiation, and her symptoms did not recur even after cessation of treatment. By the confirmation of remarkable clinical improvement in response to a H1-RA, a diagnosis of AC was made. To the best of our knowledge, this is the first report of an AC patient who presented severe cough with aphonia. J. Med. Invest. 70 : 281-284, February, 2023.

一名 33 岁的女性因持续约两个月的严重无痰咳嗽入院接受进一步检查。经长效β2受体激动剂等治疗后,她的症状没有改善。她有对非甾体抗炎药物过敏的病史。初诊时,她完全不能说话,只能用书面形式与我们交流。胸部听诊未发现喘息、啰音和其他噼啪声。实验室检查结果显示她患有轻度嗜酸性粒细胞增多症,血清免疫球蛋白 E 的总量和特异性均正常。呼出的一氧化氮分数值在正常范围内。根据这些观察结果,我们怀疑她患有特应性咳嗽(AC),并开始使用组胺 H1 受体拮抗剂(H1-RA)进行治疗。治疗开始八周后,她的咳嗽症状完全消失,并能重新开口说话,即使在停止治疗后,她的症状也没有复发。经证实,她在接受 H1-RA 治疗后临床症状明显好转,因此被诊断为 AC。据我们所知,这是首例出现严重咳嗽伴发音障碍的 AC 患者的报告。J. Med.Invest.70 : 281-284, February, 2023.
{"title":"A case of atopic cough with aphonia showed a prominent response to a histamine H<sub>1</sub> receptor antagonist.","authors":"Masaki Hanibuchi, Atsushi Mitsuhashi, Atsuro Saijo, Tatsuya Kajimoto, Seidai Sato, Tetsuya Kitagawa, Yasuhiko Nishioka","doi":"10.2152/jmi.70.281","DOIUrl":"10.2152/jmi.70.281","url":null,"abstract":"<p><p>A 33-year-old woman admitted to our hospital for further examination of severe non-productive cough lasting for about two months. Her symptom did not ameliorate by treatments including long acting β<sub>2</sub> agonists. She had a medical history of drug allergy to non-steroidal anti-inflammatory drugs. At the initial visit, she could not speak at all and communicated with us in writing. Chest auscultation revealed no wheezes, rhonchi and other crackles. Laboratory findings showed a mild eosinophilia with normal total and specific serum immunoglobulin E. The results of an electrocardiogram, a chest X-ray and a chest CT were unremarkable. A fractional exhaled nitric oxide value was within normal limit. Based on these observations, a diagnosis of atopic cough (AC) was suspected, and we started treatment with a histamine H<sub>1</sub> receptor antagonist (H<sub>1</sub>-RA). She had become able to speak again in association with complete disappearance of cough by eight-weeks after treatment initiation, and her symptoms did not recur even after cessation of treatment. By the confirmation of remarkable clinical improvement in response to a H<sub>1</sub>-RA, a diagnosis of AC was made. To the best of our knowledge, this is the first report of an AC patient who presented severe cough with aphonia. J. Med. Invest. 70 : 281-284, February, 2023.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"70 1.2","pages":"281-284"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9820764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of the Japanese version of the 8-item Chronic Pain Acceptance Questionnaire (CPAQ-8). 日文版8项慢性疼痛接受度问卷(CPAQ-8)的验证。
IF 0.7 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2152/jmi.70.88
Takaki Fukumori, Kengo Fujishima, Kazunori Iwasa, Yumiko Takao, Yukino Kobayashi, Hiroyuki Nishie

This study aimed to examine the reliability and validity of the Japanese version of the Chronic Pain Acceptance Questionnaire (CPAQ-8J). A total of 108 outpatients with chronic pain completed the CPAQ-8 questionnaire, along with the Acceptance and Action Questionnaire-II, Hospital Anxiety and Depression Scale, Pain Disability Assessment Scale, Numerical Rating Scale, and EuroQol 5 dimensions 5-level. Confirmatory factor analyses examined the factor structure. Results indicated that the CPAQ-8J comprised a two-component factor structure. Correlations between the CPAQ-8J and each variable were as expected, except between the "pain willingness" subscale and other scales ; thus, the CPAQ-8J had a certain degree of convergent validity. Internal consistency and test-retest reliability suggest that the CPAQ-8J is reliable. The psychometric properties of the CPAQ-8J meet a certain standard ; meanwhile, some issues must be addressed for its practical application. Further research should consider the influence of cultural characteristics in practical application. J. Med. Invest. 70 : 88-93, February, 2023.

本研究旨在检验日文版慢性疼痛接受度问卷(CPAQ-8J)的信度和效度。共有108例慢性疼痛门诊患者完成了CPAQ-8问卷、接受与行动问卷- ii、医院焦虑与抑郁量表、疼痛残疾评定量表、数值评定量表和EuroQol 5维度5水平。验证性因子分析检验了因子结构。结果表明,CPAQ-8J具有双组分因子结构。CPAQ-8J与各变量之间除“疼痛意愿”子量表与其他量表之间存在相关性外,其余均与预期结果一致;因此,CPAQ-8J具有一定的收敛效度。内部一致性和重测信度表明CPAQ-8J是可靠的。CPAQ-8J的心理测量指标达到一定的标准;同时,在实际应用中也需要解决一些问题。进一步的研究应考虑文化特征在实际应用中的影响。中华医学杂志,2016,31(2):379 - 379。
{"title":"Validation of the Japanese version of the 8-item Chronic Pain Acceptance Questionnaire (CPAQ-8).","authors":"Takaki Fukumori,&nbsp;Kengo Fujishima,&nbsp;Kazunori Iwasa,&nbsp;Yumiko Takao,&nbsp;Yukino Kobayashi,&nbsp;Hiroyuki Nishie","doi":"10.2152/jmi.70.88","DOIUrl":"https://doi.org/10.2152/jmi.70.88","url":null,"abstract":"<p><p>This study aimed to examine the reliability and validity of the Japanese version of the Chronic Pain Acceptance Questionnaire (CPAQ-8J). A total of 108 outpatients with chronic pain completed the CPAQ-8 questionnaire, along with the Acceptance and Action Questionnaire-II, Hospital Anxiety and Depression Scale, Pain Disability Assessment Scale, Numerical Rating Scale, and EuroQol 5 dimensions 5-level. Confirmatory factor analyses examined the factor structure. Results indicated that the CPAQ-8J comprised a two-component factor structure. Correlations between the CPAQ-8J and each variable were as expected, except between the \"pain willingness\" subscale and other scales ; thus, the CPAQ-8J had a certain degree of convergent validity. Internal consistency and test-retest reliability suggest that the CPAQ-8J is reliable. The psychometric properties of the CPAQ-8J meet a certain standard ; meanwhile, some issues must be addressed for its practical application. Further research should consider the influence of cultural characteristics in practical application. J. Med. Invest. 70 : 88-93, February, 2023.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"70 1.2","pages":"88-93"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9478157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of the Pre-operative Neutrophil-lymphocyte Ratio as the Predictive Marker of Post-operative Weight Loss and Improving Diabetes in Sleeve Gastrectomy. 术前中性粒细胞-淋巴细胞比值作为袖胃切除术术后体重减轻和糖尿病改善的预测指标的影响
IF 0.7 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2152/jmi.70.140
Hideya Kashihara, Mitsuo Shimada, Kozo Yoshikawa, Takuya Tokunaga, Toshihiro Nakao, Masaaki Nishi, Chie Takasu, Yuma Wada, Toshiaki Yoshimoto

Purpose: The aim was to investigate the impact of the neutrophil-lymphocyte ratio (NLR) in sleeve gastrectomy (SG).

Methods: 15 obese patients were enrolled in this study ; mean body weight (BW) 127.5kg ; mean body mass index (BMI) 46.7kg/m2. 10 of these were diabetics who underwent a SG. The impact of the pre-operative NLR on the percentage of excess weight loss (%EWL) and remission of diabetes 1 year post-operative were examined.

Results: The %EWL at 1 year post-operative were 46.3%. Improvements were also evident in the diabetes at 1 year post-operative : complete remission (CR) 40%, partial remission (PR) 20% and Improve 40%. Comparing pre-operative NLR in %EWL<50% and ≧50% in 1 year post-operative, <50% was 2.64 and ≧50% was 2.03. The NLR in CR and PR was significantly lower than that in Improve.

Conclusions: The pre-operative NLR may be a predictive marker of weight loss and improving diabetes after SG. J. Med. Invest. 70 : 140-144, February, 2023.

目的:探讨袖胃切除术(SG)中中性粒细胞-淋巴细胞比值(NLR)的影响。方法:选取15例肥胖患者;平均体重(BW) 127.5kg;平均体重指数(BMI) 46.7kg/m2。其中10人是接受了SG的糖尿病患者。研究了术前NLR对术后1年超重减重百分比(%EWL)和糖尿病缓解的影响。结果:术后1年EWL为46.3%。术后1年糖尿病的改善也很明显:完全缓解(CR) 40%,部分缓解(PR) 20%,改善40%。结论:术前NLR可能是SG术后体重减轻和糖尿病改善的预测指标。中华医学杂志,2016,31(2):444 - 444。
{"title":"The Impact of the Pre-operative Neutrophil-lymphocyte Ratio as the Predictive Marker of Post-operative Weight Loss and Improving Diabetes in Sleeve Gastrectomy.","authors":"Hideya Kashihara,&nbsp;Mitsuo Shimada,&nbsp;Kozo Yoshikawa,&nbsp;Takuya Tokunaga,&nbsp;Toshihiro Nakao,&nbsp;Masaaki Nishi,&nbsp;Chie Takasu,&nbsp;Yuma Wada,&nbsp;Toshiaki Yoshimoto","doi":"10.2152/jmi.70.140","DOIUrl":"https://doi.org/10.2152/jmi.70.140","url":null,"abstract":"<p><strong>Purpose: </strong>The aim was to investigate the impact of the neutrophil-lymphocyte ratio (NLR) in sleeve gastrectomy (SG).</p><p><strong>Methods: </strong>15 obese patients were enrolled in this study ; mean body weight (BW) 127.5kg ; mean body mass index (BMI) 46.7kg/m<sup>2</sup>. 10 of these were diabetics who underwent a SG. The impact of the pre-operative NLR on the percentage of excess weight loss (%EWL) and remission of diabetes 1 year post-operative were examined.</p><p><strong>Results: </strong>The %EWL at 1 year post-operative were 46.3%. Improvements were also evident in the diabetes at 1 year post-operative : complete remission (CR) 40%, partial remission (PR) 20% and Improve 40%. Comparing pre-operative NLR in %EWL<50% and ≧50% in 1 year post-operative, <50% was 2.64 and ≧50% was 2.03. The NLR in CR and PR was significantly lower than that in Improve.</p><p><strong>Conclusions: </strong>The pre-operative NLR may be a predictive marker of weight loss and improving diabetes after SG. J. Med. Invest. 70 : 140-144, February, 2023.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"70 1.2","pages":"140-144"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9451926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of successful treatment with eltrombopag for severe immune-related thrombocytopenia induced by atezolizumab:Case report. 艾曲波帕成功治疗atezolizumab诱导的严重免疫相关血小板减少症一例:病例报告。
IF 0.7 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2023-01-01 DOI: 10.2152/jmi.70.516
Saki Harada, Takeshi Imakura, Seidai Sato, Hiroshi Nokihara, Yasuhiko Nishioka

Immune checkpoint inhibitors (ICIs) have shown impressive anti-tumor effects against multiple types of malignancies. Among the wide variety of immune-related adverse events (irAEs), immune-related thrombocytopenia (ITP) is relatively rare but often clinically significant and life-threatening. However, the appropriate treatment for severe ITP has not been determined. We herein report an 82-year-old male patient with non-small-cell lung cancer who developed severe ITP three weeks after starting the third course of atezolizumab. The initial combination therapy with high-dose prednisolone, intravenous immunoglobulin and platelet transfusion was ineffective. However, additional treatment with eltrombopag, a thrombopoietin receptor agonist, resulted in remarkable improvement in the thrombocytopenia. J. Med. Invest. 70 : 516-520, August, 2023.

免疫检查点抑制剂(ICIs)对多种恶性肿瘤显示出令人印象深刻的抗肿瘤作用。在各种各样的免疫相关不良事件(irAE)中,免疫相关血小板减少症(ITP)相对罕见,但通常具有临床意义并危及生命。然而,严重ITP的适当治疗方法尚未确定。我们在此报告一名82岁的男性非小细胞肺癌癌症患者,他在开始第三个疗程的atezolizumab后三周出现严重的ITP。大剂量泼尼松、静脉注射免疫球蛋白和血小板输注的初始联合治疗无效。然而,使用血小板生成素受体激动剂eltrombopag进行额外治疗,可显著改善血小板减少症。J.Med.Invest。70:516-5202023年8月。
{"title":"A case of successful treatment with eltrombopag for severe immune-related thrombocytopenia induced by atezolizumab:Case report.","authors":"Saki Harada, Takeshi Imakura, Seidai Sato, Hiroshi Nokihara, Yasuhiko Nishioka","doi":"10.2152/jmi.70.516","DOIUrl":"10.2152/jmi.70.516","url":null,"abstract":"<p><p>Immune checkpoint inhibitors (ICIs) have shown impressive anti-tumor effects against multiple types of malignancies. Among the wide variety of immune-related adverse events (irAEs), immune-related thrombocytopenia (ITP) is relatively rare but often clinically significant and life-threatening. However, the appropriate treatment for severe ITP has not been determined. We herein report an 82-year-old male patient with non-small-cell lung cancer who developed severe ITP three weeks after starting the third course of atezolizumab. The initial combination therapy with high-dose prednisolone, intravenous immunoglobulin and platelet transfusion was ineffective. However, additional treatment with eltrombopag, a thrombopoietin receptor agonist, resulted in remarkable improvement in the thrombocytopenia. J. Med. Invest. 70 : 516-520, August, 2023.</p>","PeriodicalId":46910,"journal":{"name":"JOURNAL OF MEDICAL INVESTIGATION","volume":"70 3.4","pages":"516-520"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71522924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
JOURNAL OF MEDICAL INVESTIGATION
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1